
2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices
- Author
- Bart Spronck, Dimitrios Terentes-Printzios, Alberto P. Avolio, Pierre Boutouyrie, Andrea Guala, Ana Jerončić, Stéphane Laurent, Eduardo C.D. Barbosa, Johannes Baulmann, Chen-Huan Chen, Julio A. Chirinos, Stella S. Daskalopoulou, Alun D. Hughes, Azra Mahmud, Christopher C. Mayer, Jeong Bae Park, Gary L. Pierce, Aletta E. Schutte, Elaine M. Urbina, Ian B. Wilkinson, Patrick Segers (UGent) , James E. Sharman, Isabella Tan, Charalambos Vlachopoulos, Thomas Weber, Elisabetta Bianchini, Rosa Maria Bruno and [missing] on behalf of the Association for Research into Arterial Structure and Physiology (ARTERY), the European Society of Hypertension Working Group on Large Arteries, European Cooperation in Science and Technology (COST) Action VascAgeNet, North American Artery Society, ARTERY LATAM, Pulse of Asia, and Society for Arterial Stiffness—Germany-Austria-Switzerland (DeGAG)
- Organization
- Project
- Abstract
- BACKGROUND:Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new devices for assessing PWV, it has become evident that some of these devices yield results that display significant discrepancies compared with previous devices. This discrepancy underscores the importance of comprehensive validation procedures and the need for international recommendations.METHODS:A stepwise approach utilizing the modified Delphi technique, with the involvement of key scientific societies dedicated to arterial stiffness research worldwide, was adopted to formulate, through a multidisciplinary vision, a shared approach to the validation of noninvasive arterial PWV measurement devices.RESULTS:A set of recommendations has been developed, which aim to provide guidance to clinicians, researchers, and device manufacturers regarding the validation of new PWV measurement devices. The intention behind these recommendations is to ensure that the validation process can be conducted in a rigorous and consistent manner and to promote standardization and harmonization among PWV devices, thereby facilitating their widespread adoption in clinical practice.CONCLUSIONS:It is hoped that these recommendations will encourage both users and developers of PWV measurement devices to critically evaluate and validate their technologies, ultimately leading to improved consistency and comparability of results. This, in turn, will enhance the clinical utility of PWV as a valuable tool for assessing arterial stiffness and informing cardiovascular risk stratification and management in individuals with hypertension.
- Keywords
- Internal Medicine, vascular stiffness, pulse wave analysis, methods, guideline, cardiovascular diseases, aorta
Downloads
-
spronck-et-al-2023-2024-recommendations-for-validation-of-noninvasive-arterial-pulse-wave-velocity-measurement-devices.pdf
- full text (Published version)
- |
- open access
- |
- |
- 1.15 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-01HNWZSP6YAGM2ZXFRY3KXGM2J
- MLA
- Spronck, Bart, et al. “2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.” HYPERTENSION, vol. 81, no. 1, Ovid Technologies (Wolters Kluwer Health), 2024, pp. 183–92, doi:10.1161/hypertensionaha.123.21618.
- APA
- Spronck, B., Terentes-Printzios, D., Avolio, A. P., Boutouyrie, P., Guala, A., Jerončić, A., … on behalf of the Association for Research into Arterial Structure and Physiology (ARTERY), the European Society of Hypertension Working Group on Large Arteries, European Cooperation in Science and Technology (COST) Action VascAgeNet, North American Artery Society, ARTERY LATAM, Pulse of Asia, and Society for Arterial Stiffness—Germany-Austria-Switzerland (DeGAG), [missing]. (2024). 2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices. HYPERTENSION, 81(1), 183–192. https://doi.org/10.1161/hypertensionaha.123.21618
- Chicago author-date
- Spronck, Bart, Dimitrios Terentes-Printzios, Alberto P. Avolio, Pierre Boutouyrie, Andrea Guala, Ana Jerončić, Stéphane Laurent, et al. 2024. “2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.” HYPERTENSION 81 (1): 183–92. https://doi.org/10.1161/hypertensionaha.123.21618.
- Chicago author-date (all authors)
- Spronck, Bart, Dimitrios Terentes-Printzios, Alberto P. Avolio, Pierre Boutouyrie, Andrea Guala, Ana Jerončić, Stéphane Laurent, Eduardo C.D. Barbosa, Johannes Baulmann, Chen-Huan Chen, Julio A. Chirinos, Stella S. Daskalopoulou, Alun D. Hughes, Azra Mahmud, Christopher C. Mayer, Jeong Bae Park, Gary L. Pierce, Aletta E. Schutte, Elaine M. Urbina, Ian B. Wilkinson, Patrick Segers, James E. Sharman, Isabella Tan, Charalambos Vlachopoulos, Thomas Weber, Elisabetta Bianchini, Rosa Maria Bruno, and [missing] on behalf of the Association for Research into Arterial Structure and Physiology (ARTERY), the European Society of Hypertension Working Group on Large Arteries, European Cooperation in Science and Technology (COST) Action VascAgeNet, North American Artery Society, ARTERY LATAM, Pulse of Asia, and Society for Arterial Stiffness—Germany-Austria-Switzerland (DeGAG). 2024. “2024 Recommendations for Validation of Noninvasive Arterial Pulse Wave Velocity Measurement Devices.” HYPERTENSION 81 (1): 183–192. doi:10.1161/hypertensionaha.123.21618.
- Vancouver
- 1.Spronck B, Terentes-Printzios D, Avolio AP, Boutouyrie P, Guala A, Jerončić A, et al. 2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices. HYPERTENSION. 2024;81(1):183–92.
- IEEE
- [1]B. Spronck et al., “2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices,” HYPERTENSION, vol. 81, no. 1, pp. 183–192, 2024.
@article{01HNWZSP6YAGM2ZXFRY3KXGM2J, abstract = {{BACKGROUND:Arterial stiffness, as measured by arterial pulse wave velocity (PWV), is an established biomarker for cardiovascular risk and target-organ damage in individuals with hypertension. With the emergence of new devices for assessing PWV, it has become evident that some of these devices yield results that display significant discrepancies compared with previous devices. This discrepancy underscores the importance of comprehensive validation procedures and the need for international recommendations.METHODS:A stepwise approach utilizing the modified Delphi technique, with the involvement of key scientific societies dedicated to arterial stiffness research worldwide, was adopted to formulate, through a multidisciplinary vision, a shared approach to the validation of noninvasive arterial PWV measurement devices.RESULTS:A set of recommendations has been developed, which aim to provide guidance to clinicians, researchers, and device manufacturers regarding the validation of new PWV measurement devices. The intention behind these recommendations is to ensure that the validation process can be conducted in a rigorous and consistent manner and to promote standardization and harmonization among PWV devices, thereby facilitating their widespread adoption in clinical practice.CONCLUSIONS:It is hoped that these recommendations will encourage both users and developers of PWV measurement devices to critically evaluate and validate their technologies, ultimately leading to improved consistency and comparability of results. This, in turn, will enhance the clinical utility of PWV as a valuable tool for assessing arterial stiffness and informing cardiovascular risk stratification and management in individuals with hypertension.}}, author = {{Spronck, Bart and Terentes-Printzios, Dimitrios and Avolio, Alberto P. and Boutouyrie, Pierre and Guala, Andrea and Jerončić, Ana and Laurent, Stéphane and Barbosa, Eduardo C.D. and Baulmann, Johannes and Chen, Chen-Huan and Chirinos, Julio A. and Daskalopoulou, Stella S. and Hughes, Alun D. and Mahmud, Azra and Mayer, Christopher C. and Park, Jeong Bae and Pierce, Gary L. and Schutte, Aletta E. and Urbina, Elaine M. and Wilkinson, Ian B. and Segers, Patrick and Sharman, James E. and Tan, Isabella and Vlachopoulos, Charalambos and Weber, Thomas and Bianchini, Elisabetta and Bruno, Rosa Maria and on behalf of the Association for Research into Arterial Structure and Physiology (ARTERY), the European Society of Hypertension Working Group on Large Arteries, European Cooperation in Science and Technology (COST) Action VascAgeNet, North American Artery Society, ARTERY LATAM, Pulse of Asia, and Society for Arterial Stiffness—Germany-Austria-Switzerland (DeGAG), [missing]}}, issn = {{0194-911X}}, journal = {{HYPERTENSION}}, keywords = {{Internal Medicine,vascular stiffness,pulse wave analysis,methods,guideline,cardiovascular diseases,aorta}}, language = {{eng}}, number = {{1}}, pages = {{183--192}}, publisher = {{Ovid Technologies (Wolters Kluwer Health)}}, title = {{2024 recommendations for validation of noninvasive arterial pulse wave velocity measurement devices}}, url = {{http://doi.org/10.1161/hypertensionaha.123.21618}}, volume = {{81}}, year = {{2024}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: